We also show that whereas the upregulation of MRP1 and MDR1 is a direct target of NF-κB activity as reported by others in breast cancer [51], the upregulation of BCL-xL is an indirect target via the autocrine IL-6/STAT3 loop as reported in liver cirrhosis [52]. This evidence concerns the gene NFKB1 and breast cancer.